凯瑟琳·伍德Cathie Wood 最新ARK操作分析

Currently, Wood and her disruptive vision are facing a huge test. The flagship fund ARK Innovation ETF (ARKK) just had its worst weekly performance since February, falling 12.7% to the lowest level in over a year. Six out of the company's eight strategies recorded declines in 2021, with the worst performing strategy having a decline of 37%. $ARK Genomic Revolution ETF (ARKG.US)$ ARKK opened in the New York market with an initial drop of 4.8% and recovered by the closing, rising 1.5%. The fund has fallen nearly 24% this year.

ARK's actively managed ETFs made a total of 7 transactions on the day, buying 5 stocks and selling 2 stocks.

② $ARK Fintech Innovation ETF (ARKF.US)$ csi commodity equity index $ARK Innovation ETF (ARKK.US)$ Adding to their position $Signify Health (SGFY.US)$ is a leading healthcare platform that utilizes advanced analytics, technology, and a nationwide network of healthcare providers to create and support value-based payment programs.

ARKK position increased $Teladoc Health (TDOC.US)$ Teladoc is a telehealth company that provides on-demand healthcare through mobile devices, the internet, video, and phone. Its solutions connect physicians, healthcare professionals, healthcare providers, and users directly, offering a wide range of acute diagnoses such as upper respiratory infections, urinary tract infections, sinusitis, skin conditions, anxiety, smoking cessation, and more.

Sell ARKK. $Editas Medicine (EDIT.US)$Editas Medicine is a genome editing company. The company treats genetic diseases by correcting pathogenic genes.
Medicine是一家基因组编辑公司。该公司通过修正致病基因治疗遗传疾病。